Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 20/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5572195 | 0.78 | CRHR1 (0.61) | CRHR1 | |
| SCHEMBL5572134 | 0.78 | CRHR1 (0.72) | CRHR1 | |
| SCHEMBL5572198 | 0.77 | CRHR1 (0.56) | CRHR1 | |
| SCHEMBL5568276 | 0.77 | CRHR1 (0.80) | CRHR1 | |
| SCHEMBL4435611 | 0.77 | CRHR1 (0.68) | CRHR1 | |
| SCHEMBL14601147 | 0.76 | CRHR1 (0.52) | CRHR1 | |
| SCHEMBL5567816 | 0.76 | CRHR1 (0.78) | CRHR1 | |
| SCHEMBL5568918 | 0.74 | CRHR1 (0.79) | CRHR1 | |
| SCHEMBL14540603 | 0.73 | CRHR1 (0.56) | CRHR1 | |
| SCHEMBL5571874 | 0.71 | CRHR1 (0.40) | CRHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070066640-A1 | Heteroaryl-substituted pyrrolo'2,3-b1 pyridine derivatives as crf receptor antagonists | SMITHKLINE BEECHAM (CORK) LIMITED (IE) | 2007-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066640-A1 | Heteroaryl-substituted pyrrolo'2,3-b1 pyridine derivatives as crf receptor antagonists | CRHR1, CRHR2, CRH | CRHR1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.